Corvus Pharmaceuticals

Corvus Pharmaceuticals company information, Employees & Contact Information

Updated May 2026

Quick answer

Corvus Pharmaceuticals is a Biotechnology Research company and founded in 2014. It has approximately 42 employees on record. Contact data was last refreshed in May 2026. Find Corvus Pharmaceuticals's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Corvus is a unique environment for exceptional individuals who want to learn, contribute to an exceptional team, and make a difference in the lives of people with cancer. At Corvus, we take pride in our collaborative, community-based culture. We understand that the most successful teams are those that learn from each other and co-create in an environment that nurtures open, transparent communication.

Company Details

Employees
42
Founded
2014
Address
863 Mitten Road, Suite 102, Burlingame,ca 94010,united States
Phone
(650) 900-4520
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Burlingame, CA
Looking for a particular Corvus Pharmaceuticals employee's phone or email?

Corvus Pharmaceuticals Questions

News

Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2025 Financial Results on August 7, 2025 - Yahoo Finance

Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2025 Financial Results on August 7, 2025 Yahoo Finance

Corvus Pharmaceuticals Announces Data from Cohorts 1-3 of - GlobeNewswire

Corvus Pharmaceuticals Announces Data from Cohorts 1-3 of GlobeNewswire

Clinical-Stage Biotech Corvus Pharmaceuticals Sets Q2 2025 Earnings Release: Key Updates Coming August 7 - Stock Titan

Clinical-Stage Biotech Corvus Pharmaceuticals Sets Q2 2025 Earnings Release: Key Updates Coming August 7 Stock Titan

Corvus Pharmaceuticals Appoints David Moore to Board of Directors - Yahoo Finance

Corvus Pharmaceuticals Appoints David Moore to Board of Directors Yahoo Finance

Corvus Pharma (NASDAQ: CRVS) to host Nov. 4 webcast for financial results update - Stock Titan

Corvus Pharma (NASDAQ: CRVS) to host Nov. 4 webcast for financial results update Stock Titan

Corvus Pharmaceuticals Announces Presentation of Interim - GlobeNewswire

Corvus Pharmaceuticals Announces Presentation of Interim GlobeNewswire

Novo Nordisk EVP David Moore Joins Corvus Board to Advance ITK Inhibitor Platform and Commercial Strategy - Stock Titan

Novo Nordisk EVP David Moore Joins Corvus Board to Advance ITK Inhibitor Platform and Commercial Strategy Stock Titan

Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for a Phase 1b/2 Clinical Trial of Soquelitinib in China for the Treatment of Atopic Dermatitis - GlobeNewswire

Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for a Phase 1b/2 Clinical Trial of Soquelitinib in China for the Treatment of Atopic Dermatitis GlobeNewswire

Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data at the Keystone Symposia on Systemic Autoimmune and Autoinflammatory Diseases - Yahoo Finance

Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data at the Keystone Symposia on Systemic Autoimmune and Autoinflammatory Diseases Yahoo Finance

Top Corvus Pharmaceuticals Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant